BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8735587)

  • 1. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
    Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
    Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
    Vakharia D; Mizejewski GJ
    Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
    Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
    Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
    Bennett JA; Mesfin FB; Andersen TT; Gierthy JF; Jacobson HI
    Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2211-5. PubMed ID: 11830647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
    DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
    J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
    Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
    Mizejewski G; Smith G; Butterstein G
    Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol.
    Jacobson HI; Bennett JA; Mizejewski GJ
    Cancer Res; 1990 Jan; 50(2):415-20. PubMed ID: 1688512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens.
    Mizejewski GJ; Vonnegut M; Jacobson HI
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2733-7. PubMed ID: 6189129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid.
    Mizejewski GJ; Keenan JF; Setty RP
    Biol Reprod; 1990; 42(5-6):887-98. PubMed ID: 1696509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
    Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
    J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein: the major high-affinity estrogen binder in rat uterine cytosols.
    Uriel J; Bouillon D; Aussel C; Dupiers M
    Proc Natl Acad Sci U S A; 1976 May; 73(5):1452-6. PubMed ID: 58416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
    Mizejewski GJ
    Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
    Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
    J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed estrogenic and anti-estrogenic activities of yuehchukene--a bis-indole alkaloid.
    Ng PC; Ho DD; Ng KH; Kong YC; Cheng KF; Stone G
    Eur J Pharmacol; 1994 Oct; 264(1):1-12. PubMed ID: 7828637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.
    Butterfield LH; Meng WS; Koh A; Vollmer CM; Ribas A; Dissette VB; Faull K; Glaspy JA; McBride WH; Economou JS
    J Immunol; 2001 Apr; 166(8):5300-8. PubMed ID: 11290817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
    Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
    Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
    Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
    Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of alpha-fetoprotein and derived peptides on insulin- and estrogen-induced fetotoxicity.
    Butterstein G; Morrison J; Mizejewski GJ
    Fetal Diagn Ther; 2003; 18(5):360-9. PubMed ID: 12913349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.